tirzepatide and diabetes Semaglutide treatment leads to weight loss in type 1 FDA approval for Zepbound (tirzepatide)

The study demonstrated that once-weekly subcutaneous cagrilintide alone resulted in significant and sustained body weight reductions in individuals with overweight or obesity

Research suggests that GLP-1 medications can shift microbiome composition even without probiotics

In a pinch, whole wheat tortillas or pitas also work as a pizza crust

Check lithium levels and warn patients of toxicity signs after starting one

This is also praised as a positive but could be problematic for those who want a real live experience Clinical Oversight & Safety Licensed prescribers review intake and write prescriptions , but consultation is asynchronous (portal/email/text by default) Medical care is run through partner medical groups